Sort   by:  
 Page size 
UnknownDiurnal rhythmicity in breast-milk glucocorticoids, and infant behavior and sleep at age 3 months.
Not available
S-EPMC7308244 | biostudies-literature
UnknownFingerprick blood samples to measure serum natalizumab concentrations.
Not available
S-EPMC9972227 | biostudies-literature
UnknownNo Association between Glucocorticoid Diurnal Rhythm in Breastmilk and Infant Body Composition at 3 Months.
Not available
S-EPMC6835896 | biostudies-literature
UnknownPharmacokinetic Model-Informed Precision Dosing of Natalizumab in Multiple Sclerosis.
Not available
S-EPMC12167911 | biostudies-literature
UnknownExploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis.
Not available
S-EPMC10851624 | biostudies-literature
UnknownOcrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients.
Not available
S-EPMC8175839 | biostudies-literature
UnknownNeurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
Not available
S-EPMC9679802 | biostudies-literature
UnknownOptical coherence tomography angiography reveals insights into complementary vascular and neurodegenerative mechanisms in multiple sclerosis.
Not available
S-EPMC12835921 | biostudies-literature
UnknownLow natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis.
Not available
S-EPMC12573372 | biostudies-literature
UnknownSecond asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.
Not available
S-EPMC8473558 | biostudies-literature
Sort   by:  
 Page size